| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8212858 | International Journal of Radiation Oncology*Biology*Physics | 2017 | 10 Pages |
Abstract
SAbR demonstrated excellent LC of metastatic renal cell carcinoma with a favorable safety profile when an adequate dose and coverage were applied. Multimodality treatment with surgery should be considered for reirradiation or vertebral metastasis. A higher radiation dose may be required in patients who received previous systemic therapies.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Chiachien Jake MD, PhD, Alana MS, Mu-Han PhD, Matthew BS, Derek BS, Lorel BS, Kristin MD, Jeffrey MD, MS, Neil MD, D. W. Nathan MD, PhD, Ivan MD, Vitaly MD, Jeffrey MD, Arthur MD, Jeffrey MD, Aaron MD, PhD, Xian-Jin PhD, Hak MD, Raquibul MD, PhD,